Compound Detail
CHEMBL4640640
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1ccc(/C=c2\[nH]c(=O)/c(=C/c3cccc(C(=O)c4ccc(F)cc4)c3)[nH]c2=O)o1
Basic Information
| ChEMBL ID | CHEMBL4640640 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NLQOJROCYSOUSU-FDYZEBBJSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
416.4
MW (Da)
1.99
ALogP
4
HBA
2
HBD
95.9
PSA (Ų)
0.50
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.48
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-29 | IC50 | = | 3.3 | nM | 8.48 | Cytotoxicity against human HT-29 cells assessed as reduction in cell viability a... | 32278711 |
| BXPC-3 | IC50 | = | 3.7 | nM | 8.43 | Cytotoxicity against human BxPC3 cells assessed as reduction in cell viability i... | 32278711 |
| NCI-H460 | IC50 | = | 5.3 | nM | 8.28 | Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viabilit... | 32278711 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32278711 | 10.1016/j.bmc.2020.115435 | NCI-H460 | 1 |
| 32278711 | 10.1016/j.bmc.2020.115435 | BXPC-3 | 1 |
| 32278711 | 10.1016/j.bmc.2020.115435 | HT-29 | 1 |
Data from ChEMBL 36 via Core Engine